Comprehensive characterization of DNA methylation changes in Fuchs endothelial corneal dystrophy

Area of Science:

• Ophthalmology
• Genetics
• Epigenetics

Background:

• Fuchs Endothelial Corneal Dystrophy (FECD) is a leading cause of corneal transplantation.
• While genetic links exist for rare FECD forms, the common type's causes are largely unknown.
• Epigenetic modifications in FECD have not been previously investigated.

Purpose of the Study:

• To investigate the DNA methylation landscape in Fuchs Endothelial Corneal Dystrophy (FECD).
• To compare DNA methylation profiles between normal and FECD human corneal endothelial (CE) tissues.

Main Methods:

• Utilized the Illumina Infinium HumanMethylation450 (HM450) DNA methylation array.
• Analyzed DNA methylation patterns in human corneal endothelial (CE) tissue from control and FECD patients.

Main Results:

• Distinct DNA methylation profiles were observed between control and FECD CE samples.
• Identified 10,961 differentially methylated probes, with most showing hypermethylation in FECD.
• Genes with differential methylation were associated with cytoskeletal organization, ion transport, cell differentiation, and metabolism.

Conclusions:

• Altered DNA methylation patterns are associated with Fuchs Endothelial Corneal Dystrophy (FECD).
• These epigenetic changes may contribute to the loss of corneal transparency in FECD.
• Global DNA methylation changes affect genes vital for corneal endothelial cell function.